Dr. Thomas Del Guercio, MD

Dr. Del Guercio practices at Advanced Orthopedic and Sports Medicine Institute in Freehold, New Jersey.

Dr. Del Guercio's NPI, 1699193060, was assigned on April 2, 2014. Dr. Del Guercio holds New Jersey license 25MA11153500.

Dr. Del Guercio's primary practice is Advanced Orthopedic and Sports Medicine Institute, at 301 Professional View Dr, Freehold, NJ 07728 in Monmouth County. The practice phone is (732) 720-2555.

Dr. Del Guercio's primary practice is Advanced Orthopedic and Sports Medicine Institute in Freehold, New Jersey. Dr. Del Guercio is also affiliated with Atlantic Health CentraState Medical Center. The medical group on file is Advanced Orthopedics and Sports Medicine Institute (AOSMI). Dmand AI also links Dr. Del Guercio to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Del Guercio practices, 5 sites in all. Vendor and product names are available with a free account.

Pain medicine is Dr. Del Guercio's primary specialty in the NPI Registry, under taxonomy code 208VP0000X. The record also lists pain medicine. Dr. Del Guercio is licensed in New Jersey.

CMS data shows 4,370 Medicare services from Dr. Del Guercio across 32 procedure codes in 2024, for 435 Medicare patients. Medicare paid $180,672 for them.

CMS counts 435 Medicare patients who saw Dr. Del Guercio in 2024. The largest group is 75 to 84, with 175 patients. 75% of them have arthritis, and 75% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Del Guercio's median patient age at 71, with 58% women.

In 2024, Dr. Del Guercio wrote 710 Medicare Part D claims for 183 patients. 96% of them were for generic drugs. CMS names the drug for 627 of them, across 15 drugs with 11 or more claims each, at $7,035 in total drug cost. In 2023, CMS named 573 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Del Guercio for performance year 2024, reported as part of a group. Dr. Del Guercio accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 363 general payments to Dr. Del Guercio from 33 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 68% of the total. Abbott Laboratories paid the most, $6,328.